Brief: Hin Sang Group says Hong Kong Pharmaceutical & Research entered sale purchase agreement
June 16 (Reuters) - Hin Sang Group International Holding Co Ltd 6893.HK : * Discloseable transaction acquisition of property 6893.HK * Deal for HK$68.8 million * on 15 June 2016 after trading hours, Hong Kong Pharmaceutical & Research Institute entered into sale and purchase agreement * Source text for Eikon ID:nHKS51HCn ((For more news, please click here 6893.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Hin Sang (International) Holding
See all newsBrief: Hin Sang Group (International) Says Pang Siu Hin Resigns As Executive Director
CEO
Brief: Hin Sang Group (International) Confirms Seeking Sale Of Properties At Indicative Prices
Brief: Hin Sang Group (International) Says Co Appoints Pang Tsz Yan As Executive Director
Brief: Hin Sang Group (International) Says CEO In Criminal Custody In China